Abstract
The enantiomers of methamphetamine (MAMP) and itsN-propagyl derivative, deprenyl, were labelled with carbon 11, and the tissue distribution of these labelled compounds in mice was studied. Both enantiomers of11C-MAMP rapidly entered into the brain and then disappeared according to a single exponential curve. The enantiomers of11C-deprenyl were also rapidly distributed to various organs in the same manner. With regard to elimination, however, a stereoselective, long-term retention of radioactivity in the brain, heart and lung, due to its irreversible binding with monoamine oxidase B, was observed forl-11C-deprenyl. In reserpinized mice, the initial brain uptake of both thel andd forms of11C-MAMP was significantly decreased. On the other hand, the brain uptake of both enantiomers of11C-deprenyl was slightly increased by pretreatment with reserpine. A significant and non-stereoselective elevation of the lung uptake of11C-deprenyl was also seen in reserpinized mice. In addition, both the relative tissue distribution and ratios of radioactivity in the brain compared with blood or heart at 1 and 5 min after the injection of11C-labelled methanol in mice were not changed by reserpine. These results indicate that the transport or binding processes of these amines rather than the blood flow might be altered by reserpine. There would be an important role of the pKa values of amines in both processes. The reduction of brain uptake as well as the change in ratio between brain and heart ofl-11C-MAMP in reserpinized mice 1 min after injection were reversed by treatment with amphetamine in a dose-related manner. D-Amphetamine was found to be several times more potent than the correspondingl-form in this regard. The present results reveal some possibility that the transport or binding processes of MAMP in the brain may be regulated by cathecholaminergic neurotransmission.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amaric M, Koch GF (1985) Behaviorally equivalent stressors differentially modify the monoamine altering property ofd-amphetamine. Pharmacol Biochem Behav 23:417–423
Angard E (1977) Steroselectivity in amphetamine metabolism. In: Martin WR (ed) Handbook of experimental pharmacology, vol. 45/2. Springer, Berlin Heidelberg New York, pp 13–14
Arnett CD, MacGregor RR, Fowler JS, Wolf AP (1986) Turnover of MAO-B in baboon brain determined in vivo by PET and C-11-1-deprenyl. J Nucl Med 27:982
Caldwell J, Dring LG, Williams RT (1972) Methamphetamine in man, guinea pig and the rat. Biochem J 129:11–22
Consolo S, Garattini S, Ghielnetti R, Valzelli L (1965) Concentration of amphetamine in the brain in normal or aggressive mice. J Pharm Pharmacol 17:666–667
Danielson TJ, Coutts RT, Coutts KA, Keashly R, Tang A (1985) Reserpine-induced hypothermia and its reversal by dopamine agonist. Life Sci 37:31–38
Dolfini E, Tansella M, Valzelli L, Garantianti S (1969) Further studies of the interaction between desipramine and amphetamine. Eur J Pharmacol 5:185–190
Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, Christman D, Logan J, Smith M, Sachs H, Aquilonius SM, Bjuring P, Halldin C, Hartvig P, Leenders L, Lundqvist H, Oreland L, Stålnacke CG, Långström B (1987) Mapping human brain monoamine oxidase A and B with C-11-labeled suicide inactivators and PET. Science 235:481–485
Freeman JJ, Sulser F (1972) Iprindole-amphetamine interaction in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action. J Pharmacol Exp Ther 183:307–315
Fullera RW, Hines CW (1967)d-Amphetamine levels in brain and other tissues of isolated and aggregated mice. Biochem Pharmacol 16:11–16
Hashimoto K, Inoue O, Goromaru T, Yamasaki T (1988) Changes in in vivo binding of3H-Ro15-1788 in mouse brain by reserpine. Nucl Med Biol 15:634–637
Knoll J, Magye K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393–408
Långström B, Antoni G, Gullberg P, Halldin C, Malmhorg P, Nårgen K, Rinmland A, Svärd H (1987) Synthesis ofl- andd-methyl-11C-methionine. J Nucl Med 28:1037–1040
Lemberger L, Witt ED, Davis JM, Kopin IJ (1970) The effects of haloperidol and chlorpromazine on amphetamine metabolism and amphetamine stereotype behavior in the rat. J Pharmacol Exp Ther 174:428–433
Lesage A, Benedetti MS, Rumigny JF (1985) Evidence that (+) (H-3) amphetamine binds to acceptor sites are not MAO A. Biochem Pharmacol 34:3000–3002
Lesher GA, Spratto GR (1978) Potentiation of hexoharbital and amphetamine effects in male and female rats physically dependent on morphine. Psychopharmacology 57:175–183
Lew C, Iversen SD, Iverson LL (1971) Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant action ofd-amphetamine in mice. Eur J Pharmacol 14:351–359
MacGregor RR, Haldin C, Fowler JS, Wolf AP, Arnett CD, Långström B, Alexoff D (1985) Selective irreversible in vivo binding of C-11-clogyline and C-11-1-deprenyl in mice. Potential for measurement of functional monoamine oxidase activity in brain by using positron emission tomography. Biochem Pharmacol 34:3207–3210
Maclennan AJ, Maiyer SF (1983) Coping and the stress-induced potentiation of stimulant stereotyp in the rat. Science 219:1091–1093
Padridge WM, Connor JD (1973) Saturable transport of amphetamine across the blood-brain barrier. Experientia 29:302–304
Pletscher A, Brodie BB, Shore PA (1955) Serotonin release as a possible mechanism of reserpine action. Science 122:374–375
Proctor CD, Kirby J, Wood MH, Wader LH, King PK (1974) Comparison of the effects ofd-amphetamine andl-amphetamine in reversing depression of mouse locomotor activity caused by reserpine. Arch Int Pharmacodyn 212:108–113
Rech RH (1964) Antagonism of reserpine behavioural depression by D-amphetamine. J Pharmacol Exp Ther 146:369–376
Robinson JB (1985) Stereoselectivity and isoenzyme selectivity of moncamine oxidase inhibitors. Enantiomers of amphetamine,N-methylamphetamine and deprenyl. Pharmacology 34:4105–4108
Robinson T, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animals models of amphetamine psychosis. Brain Res Rev 11:157–198
Schmidt CJ, Gehlert DR, Peat MA, Sonsalla PK, Hanson GR, Wamsley JK, Gibb JW (1985) Studies on the mechanism of tolerance to methamphetamine. Brain Res 343:305–313
Stolk JM, Richard H (1969) Effect of reserpine on accumulation and removal ofd-amphetamine-H-3. Biochem Pharmacol 18:2786–2788
Symes AL, Lal S, Young SN, Tsang D, Sourkes TL (1977) Effect of chronic chlorpromazine administration or prior treatment with reserpine on brain apomorphine concentration and apomorphine-induced stereotyped behaviour in the rat. Eur J Pharmacol 43:173–179
Touya JJ, Rahimian J, Grubbs DE Corbus HF, Bennett LR (1985) A noninvasive procedure for in vivo assay of lung amine endothelial receptors. J Nucl Med 26:1302–1307
Youdim MBH, Sandler M (1968) Activation of monoamine oxidase and inhibition of aldehyde dehydrogenase by reserpine. Eur J Pharmacol 4:105–107
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, O., Axelsson, S., Lundgvist, H. et al. Effect of reserpine on the brain uptake of carbon 11 methamphetamine and itsN-propagyl derivative, deprenyl. Eur J Nucl Med 17, 121–126 (1990). https://doi.org/10.1007/BF00811438
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00811438